Exosomes Match PRP for Facial Rejuvenation in Split-Face Trial
First head-to-head comparison shows adipose stem cell exosomes perform equally to platelet-rich plasma for photoaging treatment.
Summary
This split-face trial compared adipose mesenchymal stem cell-derived exosomes to platelet-rich plasma (PRP) for treating photoaged facial skin. Fifteen participants received radiofrequency microneedling with PRP on one side and exosomes on the other. Both treatments equally improved wrinkles, pigmentation, redness, texture, and overall appearance over six months. Histological analysis confirmed increased collagen I and glycosaminoglycans without significant differences between treatments. Exosomes offer advantages as a standardized, needle-free alternative that eliminates blood draw requirements.
Detailed Summary
Regenerative medicine approaches for skin rejuvenation have gained significant attention, with both exosomes and platelet-rich plasma (PRP) showing promise. However, no previous studies have directly compared these treatments in a controlled clinical setting for facial photoaging.
This investigator-blinded, split-face trial enrolled 15 participants aged 44-68 with mild to moderate photoaging. Each participant received three radiofrequency microneedling treatments at four-week intervals, with PRP applied to the right side of the face and adipose mesenchymal stem cell-derived exosomes applied to the left side. The exosome product used ExoSCRT technology to isolate pure exosomes from human adipose stem cells.
Both treatments produced equivalent improvements across all measured parameters. Overall skin appearance scores improved from 2.12 at baseline to 3.04 (PRP) and 3.14 (exosomes) at six months. The Griffiths Photonumeric Photoaging Scale showed identical 37% improvement at three months and 22% at six months for both treatments. Exosomes showed slightly greater improvement in wrinkles, redness, and texture, though differences were minimal.
Histological analysis of punch biopsies from the first 10 participants revealed increased collagen I and glycosaminoglycans in both treatment groups, with no statistically significant differences between PRP and exosomes. Both treatments were well-tolerated with only expected transient side effects like mild erythema and edema.
These findings suggest exosomes represent a viable alternative to PRP for facial rejuvenation. Key advantages include standardized composition, elimination of blood draw requirements, and potential appeal to needle-averse patients. The study establishes non-inferiority of exosomes to PRP when combined with radiofrequency microneedling, though larger trials are needed to confirm these preliminary results.
Key Findings
- Exosomes and PRP showed equivalent improvements in wrinkles, pigmentation, and skin texture
- Both treatments increased collagen I and glycosaminoglycans equally in histological analysis
- Griffiths photoaging scores improved 37% at 3 months and 22% at 6 months for both treatments
- Exosomes eliminate need for blood draw and centrifugation required for PRP
- No significant adverse events occurred with either treatment approach
Methodology
Investigator-blinded, split-face trial with 15 participants receiving three radiofrequency microneedling treatments at 4-week intervals. PRP applied to right side, exosomes to left side. Outcomes assessed via clinical photography, validated photoaging scales, and histological analysis of punch biopsies.
Study Limitations
Small sample size of 15 participants limits statistical power. Single-center study may limit generalizability. Lack of randomization in treatment allocation and relatively short 6-month follow-up period. No comparison to radiofrequency microneedling alone as control.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.